Ef. Labelle et E. Polyak, NOREPINEPHRINE STIMULATES ARACHIDONIC-ACID RELEASE FROM VASCULAR SMOOTH-MUSCLE VIA ACTIVATION OF CPLA(2), American journal of physiology. Cell physiology, 43(4), 1998, pp. 1129-1137
The mechanism of agonist-activated arachidonate release was studied in
segments of rat tail artery. Tail artery segments were prelabeled wit
h [H-3]arachidonate and then stimulated with norepinephrine (NE), and
the radioactivity of the extracellular medium was determined. NE stimu
lated arachidonate release from the tissue without increasing arachido
nic acid levels within cellular cytosol or crude membranes. About 90%
of the extracellular radioactivity was shown to be unmetabolized arach
idonate by TLC. Arachidonic acid release was not inhibited by the remo
val of the endothelium from the artery. NE exerted a half-maximal effe
ct at a concentration of 0.2 mu M. NE-stimulated arachidonate release
was not inhibited by blockers of phospholipase C (U-73122), diacylglyc
erol Lipase (RHC-80267), secretory phospholipase A(2) (manoalide), cal
cium-insensitive phospholipase A(2) (HELSS), or beta-adrenergic recept
ors (propranolol). NE-stimulated arachidonic acid release was inhibite
d by blockers of cytosolic phospholipase A(2) (cPLA(2)) (AACOCF(3)), a
lpha(1)-adrenergic receptors (prazosin), and specific G proteins (pert
ussis toxin). This indicated that NE stimulated arachidonate release f
rom vascular smooth muscle via activation of alpha(1)-adrenergic recep
tors, either G(i) or G(o), and cPLA(2). NE-activated arachidonic acid
release from vascular smooth muscle may play a role in force generatio
n by the tissue. Perhaps arachidonic acid extends the effect of NE on
one specific smooth muscle cell to its nearby neighbor cells.